Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-18-000823
Filing Date
2018-10-03
Accepted
2018-10-03 16:36:47
Documents
1
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 matinasbiofm4_oct12018.html 4  
1 matinasbiofm4_oct12018.xml 4 3442
  Complete submission text file 0000905718-18-000823.txt   4817
Mailing Address VIROPHARMA INCORP 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
WIKLER MATTHEW (Reporting) CIK: 0001195414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 181105485

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations